Profile data is unavailable for this security.
About the company
FibroBiologics Inc is a United States-based company. The Company operates as a biopharmaceutical company. It is focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. It also develops biologic cures and treatments for chronic diseases, including degenerative disc disease, multiple sclerosis, wound healing, and cancer, and anti-aging extension of life applications such as thymic involution reversal and splenic involution reversal.
- Revenue in USD (TTM)0.00
- Net income in USD-22.53m
- Incorporated2021
- Employees10.00
- LocationFibrobiologics Inc455 E. Medical Center Blvd, Suite 300HOUSTON 77598United StatesUSA
- Phone+1 (281) 671-5150
- Fax+1 (302) 655-5049
- Websitehttps://fibrobiologics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fennec Pharmaceuticals Inc | 44.95m | 2.84m | 181.70m | 36.00 | 181.84 | 59.80 | 63.89 | 4.04 | 0.0366 | 0.0366 | 1.62 | 0.1112 | 0.9878 | 1.15 | 7.52 | -- | 6.25 | -73.43 | 7.37 | -84.32 | 96.19 | -- | 6.33 | -383.28 | 6.72 | 1.84 | 0.9087 | -- | 1,284.50 | -- | 32.34 | -- | -- | -- |
Rigel Pharmaceuticals Inc | 120.35m | -19.80m | 181.73m | 147.00 | -- | -- | -- | 1.51 | -1.13 | -1.13 | 6.90 | -1.81 | 0.9623 | 0.9241 | 4.23 | 818,680.30 | -15.83 | -28.82 | -30.14 | -47.26 | 93.22 | 97.88 | -16.45 | -35.76 | 1.17 | -2.91 | 2.13 | -- | -2.79 | 21.30 | 57.16 | -- | 68.45 | -- |
Adverum Biotechnologies Inc | 0.00 | -112.90m | 182.25m | 121.00 | -- | 0.9997 | -- | -- | -10.23 | -10.23 | 0.00 | 8.78 | 0.00 | -- | -- | 0.00 | -41.55 | -36.39 | -47.50 | -39.04 | -- | -- | -- | -5,279.60 | -- | -- | 0.00 | -- | -- | 17.43 | 24.18 | -- | -0.0247 | -- |
G1 Therapeutics Inc | 84.04m | -30.59m | 184.03m | 100.00 | -- | 6.63 | -- | 2.19 | -0.6146 | -0.6146 | 1.55 | 0.531 | 0.6367 | 0.4852 | 6.07 | 840,410.00 | -23.18 | -47.06 | -30.95 | -52.64 | 91.89 | -- | -36.40 | -268.59 | 2.55 | -3.31 | 0.6084 | -- | 60.84 | -- | 67.49 | -- | -- | -- |
Acumen Pharmaceuticals Inc | 0.00 | -55.94m | 184.44m | 51.00 | -- | 0.7039 | -- | -- | -1.05 | -1.05 | 0.00 | 4.36 | 0.00 | -- | -- | 0.00 | -22.89 | -- | -23.72 | -- | -- | -- | -- | -- | -- | -- | 0.1034 | -- | -- | -- | -22.20 | -- | -- | -- |
Rani Therapeutics Holdings Inc | 0.00 | -33.08m | 186.56m | 140.00 | -- | 24.12 | -- | -- | -1.29 | -1.29 | 0.00 | 0.1534 | 0.00 | -- | -- | 0.00 | -87.80 | -- | -140.92 | -- | -- | -- | -- | -- | -- | -28.75 | 0.6695 | -- | -- | -- | -11.06 | -- | -- | -- |
Biomea Fusion Inc | 0.00 | -127.27m | 191.23m | 110.00 | -- | 1.41 | -- | -- | -3.57 | -3.57 | 0.00 | 3.77 | 0.00 | -- | -- | 0.00 | -90.54 | -- | -107.35 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -43.29 | -- | -- | -- |
Fibrobiologics Inc | 0.00 | -22.53m | 192.53m | 10.00 | -- | -- | -- | -- | -1.03 | -1.03 | 0.00 | -0.1181 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -272.15 | -- | -- | -- |
Pyxis Oncology Inc | 16.15m | -57.80m | 192.57m | 51.00 | -- | 1.04 | -- | 11.93 | -1.39 | -1.39 | 0.368 | 3.13 | 0.0801 | -- | -- | 322,920.00 | -28.68 | -- | -30.64 | -- | 97.06 | -- | -358.00 | -- | -- | -- | 0.00 | -- | -- | -- | 38.87 | -- | -- | -- |
Metagenomi Inc | -100.00bn | -100.00bn | 194.06m | 237.00 | -- | 0.7041 | -- | -- | -- | -- | -- | 7.36 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | 160.21 | -- | -56.57 | -- | -- | -- |
Candel Therapeutics Inc | 0.00 | -37.37m | 195.50m | 42.00 | -- | 32.25 | -- | -- | -1.29 | -1.29 | 0.00 | 0.2037 | 0.00 | -- | -- | 0.00 | -75.90 | -- | -93.79 | -- | -- | -- | -- | -- | -- | -38.49 | 0.7674 | -- | -100.00 | -- | -101.87 | -- | -- | -- |
Coherus Biosciences Inc | 301.87m | -59.29m | 199.62m | 249.00 | -- | -- | -- | 0.6613 | -0.7801 | -0.7801 | 2.86 | -0.7211 | 0.5178 | 3.17 | 1.71 | 986,506.60 | -10.17 | -21.43 | -23.51 | -29.32 | 41.46 | 79.01 | -19.64 | -36.56 | 1.05 | -3.87 | 1.21 | -- | 21.89 | -- | 18.46 | -- | -18.37 | -- |
Trevi Therapeutics Inc | 0.00 | -33.57m | 200.04m | 25.00 | -- | 2.71 | -- | -- | -0.338 | -0.338 | 0.00 | 1.05 | 0.00 | -- | -- | 0.00 | -34.47 | -47.39 | -38.08 | -54.41 | -- | -- | -- | -- | -- | -- | 0.0017 | -- | -- | -- | 0.2984 | -- | -2.81 | -- |
Lineage Cell Therapeutics Inc | 8.00m | -23.66m | 200.15m | 75.00 | -- | 2.76 | -- | 25.01 | -0.1344 | -0.1344 | 0.0455 | 0.3836 | 0.0722 | -- | 57.16 | 106,706.70 | -21.32 | -19.53 | -24.82 | -22.59 | 91.88 | 89.13 | -295.30 | -370.88 | -- | -- | 0.0018 | -- | -39.16 | 12.39 | 18.22 | -- | -27.16 | -- |
XBiotech Inc | 0.00 | -30.74m | 200.41m | 92.00 | -- | 0.9574 | -- | -- | -1.01 | -1.01 | 0.00 | 6.87 | 0.00 | -- | -- | 0.00 | -13.08 | 31.88 | -13.68 | 33.27 | -- | -- | -- | 877.30 | -- | -- | 0.0456 | 0.00 | -100.00 | -- | 25.36 | -- | 24.30 | -- |
Generation Bio Co | 9.96m | -169.06m | 202.25m | 174.00 | -- | 1.53 | -- | 20.30 | -2.56 | -2.56 | 0.1509 | 1.99 | 0.0278 | -- | 10.98 | 57,258.62 | -47.14 | -36.96 | -50.75 | -39.21 | -- | -- | -1,696.87 | -8,879.44 | -- | -- | 0.00 | -- | -- | 177.31 | 7.34 | -- | 19.61 | -- |
Data as of Jul 22 2024. Currency figures normalised to Fibrobiologics Inc's reporting currency: US Dollar USD
Holder | Shares | % Held |
---|---|---|
Millennium Management LLCas of 31 Mar 2024 | 209.23k | 0.64% |
Transform Wealth LLCas of 30 Jun 2024 | 133.89k | 0.41% |
HRT Financial LLCas of 31 Mar 2024 | 57.34k | 0.18% |
Marshall Wace LLPas of 31 Mar 2024 | 52.03k | 0.16% |
State Street Global Advisors Trust Co.as of 04 Jul 2024 | 40.00k | 0.12% |
ERn Financial LLCas of 30 Jun 2024 | 31.82k | 0.10% |
Citigroup Global Markets, Inc. (Investment Management)as of 31 Mar 2024 | 30.42k | 0.09% |
ExodusPoint Capital Management LPas of 31 Mar 2024 | 25.59k | 0.08% |
JPMorgan Securities LLC (Investment Management)as of 31 Mar 2024 | 22.63k | 0.07% |
Saxon Interests, Inc.as of 30 Jun 2024 | 21.21k | 0.07% |
More ▼
Data from 31 Mar 2024 - 18 Jul 2024Source: FactSet Research Systems Inc.